Filter posts

Upcoming Webinar: The Future of Partnering

We’ve talked before about the new and improved BIO One-on-One™ partnering system coming for BIO …

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, …

Session Recap: Digital Health—Early Successes for Investors and Biotech R&D Productivity

Digital health has the potential to improve the life science industry by combining traditional and …

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, …

2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins

Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …

Electroceuticals and Digital Drug Delivery: Neurological Stimulation and Beyond

Some of the most experienced executives in biotechnology have begun asking themselves, “Can we foresee …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

Fireside Chat with Ken Drazan, MD, Head of Johnson & Johnson Innovation

Day one of the BIO Investor Forum featured a Fireside Chat with Ken Drazan, MD, …

BIO 2015 – Call for Sessions Extended

It’s not too late to submit a session proposal for the 2015 BIO International Convention. …